Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c01435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Gustave Adouvi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Acrylates. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: European Commission, Deutsche Forschungsgemeinschaft, Friedrich Naumann Stiftung.
Abstract (Originalsprache)
The retinoid X receptors (RXRs) are ligand-activated transcription factors involved in, for example, differentiation and apoptosis regulation. Currently used reference RXR agonists suffer from insufficient specificity and poor physicochemical properties, and improved tools are needed to capture the unexplored therapeutic potential of RXR. Endogenous vitamin A-derived RXR ligands and the natural product RXR agonist valerenic acid comprise acrylic acid residues with varying substitution patterns to engage the critical ionic contact with the binding site arginine. To mimic and exploit this natural ligand motif, we probed its structural fusion with synthetic RXR modulator scaffolds, which had profound effects on agonist activity and remarkably boosted potency of an oxaprozin-derived RXR agonist chemotype. Bioisosteric replacement of the acrylic acid to overcome its pan-assay interference compounds (PAINS) character enabled the development of a highly optimized RXR agonist chemical probe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany.
- Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
ORCID-Profile: Sabine Willems, Jörg Pabel, Daniel Merk
Förderung
- European Commission
- Deutsche Forschungsgemeinschaft
- Friedrich Naumann Stiftung
Zitieren
APA
Adouvi, G., Nawa, F., Ballarotto, M., Rüger, L. A., Knümann, L., Kasch, T., Arifi, S., Schubert-Zsilavecz, M., Willems, S., Marschner, J. A., Pabel, J., & Merk, D. (2023). Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01435
Vancouver
Adouvi G, Nawa F, Ballarotto M, Rüger LA, Knümann L, Kasch T, et al. Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01435
BibTeX
@article{Adouvi2023,
author = {Adouvi, Gustave and Nawa, Felix and Ballarotto, Marco and Rüger, Lorena Andrea and Knümann, Loris and Kasch, Till and Arifi, Silvia and Schubert-Zsilavecz, Manfred and Willems, Sabine and Marschner, Julian A and Pabel, Jörg and Merk, Daniel},
title = {Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c01435}
}
EUVIMED